930 related articles for article (PubMed ID: 25622193)
21. Molecular Pathways: Targeting the Stimulator of Interferon Genes (STING) in the Immunotherapy of Cancer.
Corrales L; Gajewski TF
Clin Cancer Res; 2015 Nov; 21(21):4774-9. PubMed ID: 26373573
[TBL] [Abstract][Full Text] [Related]
22. Natural killer cells promote early CD8 T cell responses against cytomegalovirus.
Robbins SH; Bessou G; Cornillon A; Zucchini N; Rupp B; Ruzsics Z; Sacher T; Tomasello E; Vivier E; Koszinowski UH; Dalod M
PLoS Pathog; 2007 Aug; 3(8):e123. PubMed ID: 17722980
[TBL] [Abstract][Full Text] [Related]
23. Dual antibody therapy to harness the innate anti-tumor immune response to enhance antibody targeting of tumors.
Chester C; Marabelle A; Houot R; Kohrt HE
Curr Opin Immunol; 2015 Apr; 33():1-8. PubMed ID: 25576932
[TBL] [Abstract][Full Text] [Related]
24. Killer dendritic cells: mechanisms of action and therapeutic implications for cancer.
Wesa AK; Storkus WJ
Cell Death Differ; 2008 Jan; 15(1):51-7. PubMed ID: 17948028
[TBL] [Abstract][Full Text] [Related]
25. Novel insights into the immunomodulatory role of the dendritic cell and macrophage-expressed C-type lectin MGL.
van Kooyk Y; Ilarregui JM; van Vliet SJ
Immunobiology; 2015 Feb; 220(2):185-92. PubMed ID: 25454488
[TBL] [Abstract][Full Text] [Related]
26. Engaging Pattern Recognition Receptors in Solid Tumors to Generate Systemic Antitumor Immunity.
Brown M
Cancer Treat Res; 2022; 183():91-129. PubMed ID: 35551657
[TBL] [Abstract][Full Text] [Related]
27. Innate Valpha14(+) natural killer T cells mature dendritic cells, leading to strong adaptive immunity.
Fujii S; Shimizu K; Hemmi H; Steinman RM
Immunol Rev; 2007 Dec; 220():183-98. PubMed ID: 17979847
[TBL] [Abstract][Full Text] [Related]
28. STING: a master regulator in the cancer-immunity cycle.
Zhu Y; An X; Zhang X; Qiao Y; Zheng T; Li X
Mol Cancer; 2019 Nov; 18(1):152. PubMed ID: 31679519
[TBL] [Abstract][Full Text] [Related]
29. IFN-alpha in the generation of dendritic cells for cancer immunotherapy.
Santini SM; Lapenta C; Santodonato L; D'Agostino G; Belardelli F; Ferrantini M
Handb Exp Pharmacol; 2009; (188):295-317. PubMed ID: 19031032
[TBL] [Abstract][Full Text] [Related]
30. The STING pathway and the T cell-inflamed tumor microenvironment.
Woo SR; Corrales L; Gajewski TF
Trends Immunol; 2015 Apr; 36(4):250-6. PubMed ID: 25758021
[TBL] [Abstract][Full Text] [Related]
31. Immune system recognition of Trypanosoma cruzi.
Tarleton RL
Curr Opin Immunol; 2007 Aug; 19(4):430-4. PubMed ID: 17651955
[TBL] [Abstract][Full Text] [Related]
32. Systems approaches to unravel innate immune cell diversity, environmental plasticity and functional specialization.
Soumelis V; Pattarini L; Michea P; Cappuccio A
Curr Opin Immunol; 2015 Feb; 32():42-7. PubMed ID: 25588554
[TBL] [Abstract][Full Text] [Related]
33. The cytotoxic protease granzyme M is expressed by lymphocytes of both the innate and adaptive immune system.
de Koning PJ; Tesselaar K; Bovenschen N; Colak S; Quadir R; Volman TJ; Kummer JA
Mol Immunol; 2010 Jan; 47(4):903-11. PubMed ID: 19896187
[TBL] [Abstract][Full Text] [Related]
34. Innate Immune Cells: A Potential and Promising Cell Population for Treating Osteosarcoma.
Wang Z; Wang Z; Li B; Wang S; Chen T; Ye Z
Front Immunol; 2019; 10():1114. PubMed ID: 31156651
[TBL] [Abstract][Full Text] [Related]
35. Are macrophages, myeloid derived suppressor cells and neutrophils mediators of local suppression in healthy and cancerous tissues in aging hosts?
Jackaman C; Nelson DJ
Exp Gerontol; 2014 Jun; 54():53-7. PubMed ID: 24291067
[TBL] [Abstract][Full Text] [Related]
36. Promising Targets for Cancer Immunotherapy: TLRs, RLRs, and STING-Mediated Innate Immune Pathways.
Li K; Qu S; Chen X; Wu Q; Shi M
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28216575
[TBL] [Abstract][Full Text] [Related]
37. Innate immune sensing of cancer: clues from an identified role for type I IFNs.
Gajewski TF; Fuertes MB; Woo SR
Cancer Immunol Immunother; 2012 Aug; 61(8):1343-7. PubMed ID: 22722449
[TBL] [Abstract][Full Text] [Related]
38. Innate immune recognition and suppression of tumors.
Hayakawa Y; Smyth MJ
Adv Cancer Res; 2006; 95():293-322. PubMed ID: 16860661
[TBL] [Abstract][Full Text] [Related]
39. Dendritic cells fused with allogeneic colorectal cancer cell line present multiple colorectal cancer-specific antigens and induce antitumor immunity against autologous tumor cells.
Koido S; Hara E; Homma S; Torii A; Toyama Y; Kawahara H; Watanabe M; Yanaga K; Fujise K; Tajiri H; Gong J; Toda G
Clin Cancer Res; 2005 Nov; 11(21):7891-900. PubMed ID: 16278414
[TBL] [Abstract][Full Text] [Related]
40. Harnessing the exosome-induced immune response for cancer immunotherapy.
Gehrmann U; Näslund TI; Hiltbrunner S; Larssen P; Gabrielsson S
Semin Cancer Biol; 2014 Oct; 28():58-67. PubMed ID: 24859748
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
